Pfizer sues Johnson & Johnson over anti-competitive tactics
It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug
Fri, Sep 22, 2017 - 5:50 AM
Washington
A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.
Pfizer filed a lawsuit on Wednesday against fellow...
Register to read this article. Log in if you are already a subscriber.Register to read this article. Log in if you are already a subscriber.Please log in or subscribe to continue reading.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes